Skip to main content
. 2020 Dec 21;28(4):1234–1243. doi: 10.1111/ene.14651

Table 1.

Patient characteristics

All (n = 222) Favorable (n = 119) Unfavorable (n = 103) p
Age, years 73.54 (19.99) 68.80 (18.23) 79.20 (17.70) <0.001
Women, n(%) 134 (60) 72 (61) 62 (60) 1.000
Risk factors, n(%)
Diabetes mellitus 39 (18) 15 (13) 24 (23) 0.051
Atrial fibrillation 92 (42) 39 (33) 53 (51) 0.006
Hypertension 148 (67) 69 (58) 79 (77) 0.004
Dyslipidemia 133 (60) 75 (63) 58 (57) 0.410
Smoker 49 (24) 35 (31) 14 (16) 0.013
Coronary heart disease 35 (16) 19 (16) 16 (16) 1.000
Peripheral arterial disease  8 (4) 3 (3) 5 (5) 0.474
Past ischemic events 30 (14) 15 (13) 15 (15) 0.698
Previous medication, n(%)
Antiplatelet therapy 70 (32) 30 (25) 40 (39) 0.031
Oral anticoagulation 21 (9) 10 (8) 11 (11) 0.648
Statin therapy 49 (22) 25 (21) 24 (23) 0.747
Antihypertensive therapy 130 (59) 61 (51) 69 (67) 0.020
On admission, n(%)
Independent before stroke 184 (92) 104 (96) 80 (88) 0.032
NIHSS baseline 13 (9) 12 (7) 15 (9.5) 0.005
Systolic blood pressure, mmHg 153 (36) 147 (29) 160 (35) 0.004
Diastolic blood pressure, mmHg 82 (25) 81 (22) 84.5 (27.5) 0.585
Glucose, mmol/L 6.5 (2.02) 6.2 (1.7) 6.75 (2.5) 0.010
HbA1c, % 5.8 (0.6) 5.8 (0.5) 5.8 (0.9) 0.650
LDL, mmol/L 2.41 (1.41) 2.53 (1.34) 2.36 (1.38) 0.252
HDL, mmol/L 1.37 (0.57) 1.33 (0.56) 1.44 (0.6) 0.423
Triglycerides, mmol/L 1.32 (0.84) 1.33 (0.77) 1.27 (0.85) 0.825
C‐reactive protein, mg/L 3 (5) 3 (3) 4 (8) 0.015
International Normalized Ratio 1.01 (0.07) 1.01 (0.05) 1.02 (0.07) 0.247
Infarct side (left), n(%) 99 (45) 54 (45) 45 (44) 0.892
IVT, n(%) 103 (46) 58 (49) 45 (44) 0.501
Onset to imaging, min 132 (210.5) 128 (187) 149.5 (243) 0.383
Onset to groin puncture, min 216 (231) 210.5 (190.75) 230 (271) 0.540
General anesthesia, n(%) 112 (52) 58 (51) 54 (53) 0.786
Collateralization status, n(%)
Good 115 (53) 69 (59) 46 (46) 0.124
Moderate 78 (36) 39 (33) 39 (39)
Poor 25 (11) 10 (8) 15 (15)
Perfusion imaging, n(%)
Volume core 19.90 (27.77) 16.50 (20.82) 23.83 (33.77) 0.543
Volume hypoperfusion 137.78 (72.25) 132.32 (69.94) 144.10 (74.68) 0.142
Volume of tissue at risk 117.88 (66.06) 115.82 (60.98) 120.26 (71.70) 0.692
rCBF core 11.83 (7.05) 13.04 (6.76) 10.43 (7.15) 0.002
rCBF penumbra 18.49 (7.59) 19.43 (7.93) 17.40 (7.06) 0.057
rCBV core 1.62 (0.93) 1.74 (0.90) 1.48 (0.95) 0.037
rCBV penumbra 3.11 (1.44) 3.11 (1.32) 3.11 (1.57) 0.728
After treatment
TICI score, n(%)
0 10 (5) 2 (2) 8 (8) 0.011
1 10 (5) 2 (2) 8 (8)
2a 27 (12) 13 (11) 14 (13)
2b 75 (33) 39 (32) 36 (35)
3 100 (45) 63 (53) 37 (36)
NIHSS score after 24 h 6 (10) 4 (4.5) 11 (9.75) <0.001
ICH (SITS‐MOST) , n(%) 5 (2) 1 (1) 4 (4) 0.185

Data are frequencies (percentages), as indicated, for categorical variables and median (interquartile range) for continuous variables of clinical data and patient characteristics. For perfusion imaging, mean (standard deviation) of core and penumbral volumes (cc), as well as their regional blood flow (ml/100 ml/min) and regional blood volume (ml/100 ml) are shown. Differences in patients with favorable (modified Rankin scale [mRS] score 0–2) and unfavorable outcome (mRS score 3–6) were tested with Fisher's (categorical) and Wilcoxon's (continuous) test using a significance level of 5%.

Abbreviations: HbA1c, glycated hemoglobin; HDL, high‐density lipoprotein; ICH, intracerebral hemorrhage; IVT, intravenous thrombolysis; LDL, low‐density lipoprotein; NIHSS, National Institutes of Health Stroke Scale; rCBF, regional cerebral blood flow; rCBV, regional cerebral blood volume; TICI, Thrombolysis In Cerebral Infarction scale.